Combined adjuvant chemotherapy and radiation was associated with improved survival in patients with ad vanced-stage disease compared with either modality alone. The efficacy of fertility-sparing treatment with a high-dose of medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia was proven by this prospective trial. Even in responders, however, close follow-up is required because of the substantial rate of recurrence. Uterine papillary serous carcinoma harbors a moderate prognosis, with age, stage and histology as significant prognosticators. Conservative surgery followed by adjuvant chemotherapy and pelvic radiotherapy can be suggested as an appropriate treatment approach for patients treated with curative intent. The high rate of lymphatic metastasis above the inferior mesenteric artery indicates the need for systematic pelvic and para-aortic lymphadenectomy (vs sampling) up to the renal vessels. The latter should include consideration of excision of the gonadal veins. Conversely, lymphadenectomy does not benefit patients with grade 1 and 2 endometrioid lesions with myometrial invasion ≤ 50% and primary tumor diameter ≤ 2 cm. This study emphasizes the importance of lymph node dissection in endometrial cancer. Lymph node dissection is essential for accurate surgical staging, which remains the most important prognostic factor. In addition to well-known clinicopathologic risk factors for survival, the removal of 10 or more regional lymph nodes was associated with improved overall survival in lower-stage, older patients who received no adjuvant therapy or brachytherapy only. A clinically significant number of patients will have more advanced disease than predicted by preoperative or intraoperative prognostic factors. These predictors should not be relied on in the staging of endometrial cancer. The findings of the current study suggested that recurrence-free survival may be shorter among black women with stage I endometrial cancer, even in a clinical trial setting in which patients received similar treatment and follow-up. This increased risk of recurrence ap peared to be most evident in black women with endometrial cancer who maintained ERT after primary treatment. 
Uterine papillary serous carcinoma harbors a moderate prognosis, with age, stage and histology as significant prognosticators. Conservative surgery followed by adjuvant chemotherapy and pelvic radiotherapy can be suggested as an appropriate treatment approach for patients treated with curative intent. The high rate of lymphatic metastasis above the inferior mesenteric artery indicates the need for systematic pelvic and para-aortic lymphadenectomy (vs sampling) up to the renal vessels. The latter should include consideration of excision of the gonadal veins. Conversely, lymphadenectomy does not benefit patients with grade 1 and 2 endometrioid lesions with myometrial invasion ≤ 50% and primary tumor diameter ≤ 2 cm. This study emphasizes the importance of lymph node dissection in endometrial cancer. Lymph node dissection is essential for accurate surgical staging, which remains the most important prognostic factor. In addition to well-known clinicopathologic risk factors for survival, the removal of 10 or more regional lymph nodes was associated with improved overall survival in lower-stage, older patients who received no adjuvant therapy or brachytherapy only. A clinically significant number of patients will have more advanced disease than predicted by preoperative or intraoperative prognostic factors. These predictors should not be relied on in the staging of endometrial cancer. The findings of the current study suggested that recurrence-free survival may be shorter among black women with stage I endometrial cancer, even in a clinical trial setting in which patients received similar treatment and follow-up. This increased risk of recurrence ap peared to be most evident in black women with endometrial cancer who maintained ERT after primary treatment. Robotic-assisted hysterectomy with staging is feasible and preferable over the laparotomy technique and may be preferable over the traditional laparoscopy technique in women with endometrial cancer. Further study is necessary to determine long-term oncologic outcomes.
